Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$20.22 - $27.36 $3.03 Million - $4.1 Million
-150,000 Reduced 75.0%
50,000 $1.06 Million
Q2 2023

Aug 09, 2023

SELL
$19.39 - $28.9 $1.45 Million - $2.17 Million
-75,000 Reduced 27.27%
200,000 $5.4 Million
Q1 2023

May 10, 2023

SELL
$12.71 - $21.17 $699,050 - $1.16 Million
-55,000 Reduced 16.67%
275,000 $5.41 Million
Q4 2022

Feb 10, 2023

SELL
$11.23 - $19.44 $1.46 Million - $2.53 Million
-130,000 Reduced 28.26%
330,000 $4.49 Million
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $915,000 - $1.4 Million
-75,000 Reduced 14.02%
460,000 $8.03 Million
Q2 2022

Aug 16, 2022

BUY
$12.05 - $22.74 $723,000 - $1.36 Million
60,000 Added 12.63%
535,000 $7.06 Million
Q1 2022

May 11, 2022

SELL
$18.32 - $23.03 $1.37 Million - $1.73 Million
-75,000 Reduced 13.64%
475,000 $10.7 Million
Q4 2021

Feb 14, 2022

BUY
$18.75 - $24.8 $2.81 Million - $3.72 Million
150,000 Added 37.5%
550,000 $12.2 Million
Q3 2021

Nov 12, 2021

BUY
$19.65 - $31.89 $2.85 Million - $4.62 Million
145,000 Added 56.86%
400,000 $8.57 Million
Q2 2021

Aug 13, 2021

SELL
$29.4 - $35.96 $588,000 - $719,200
-20,000 Reduced 7.27%
255,000 $8.03 Million
Q1 2021

May 12, 2021

SELL
$28.09 - $34.02 $3.09 Million - $3.74 Million
-110,000 Reduced 28.57%
275,000 $8.75 Million
Q4 2020

Feb 10, 2021

BUY
$20.44 - $30.88 $2.86 Million - $4.32 Million
140,000 Added 57.14%
385,000 $11.3 Million
Q3 2020

Nov 12, 2020

BUY
$15.68 - $24.28 $2.19 Million - $3.39 Million
139,800 Added 132.89%
245,000 $5.81 Million
Q2 2020

Aug 11, 2020

SELL
$10.56 - $18.46 $1.08 Million - $1.88 Million
-101,800 Reduced 49.18%
105,200 $1.68 Million
Q1 2020

May 14, 2020

BUY
$8.36 - $22.67 $1.73 Million - $4.69 Million
207,000 New
207,000 $2.47 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $568M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.